Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human HeartA Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study

被引：0
|
作者：
Håkan Walfridsson
Birgitta Johansson
Anders Englund
Göran Kennebäck
Jonas Schwieler
Ole Kongstad
Karin Wåhlander
Anders R. Malm
Nils Edvardsson
机构：
[1] University Hospital,Department of Cardiology
[2] Sahlgrenska University Hospital,Department of Cardiology
[3] Örebro University Hospital,Department of Cardiology
[4] Karolinska University Hospital,Department of Cardiology
[5] Karolinska University Hospital,Department of Cardiology
[6] University Hospital,Department of Cardiology
[7] AstraZeneca R&D,undefined
[8] Sahlgrenska Academy at Sahlgrenska University Hospital,undefined
来源：
Clinical Drug Investigation | 2010年 / 30卷
关键词：
International Normalize Ratio; Sinus Rhythm; Atrial Flutter; Activate Partial Thromboplastin Time; Dabigatran Etexilate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: AZD0837 is an investigational oral anticoagulant that is bio-converted to its active form, AR-H067637, a selective direct thrombin inhibitor.
引用
收藏
页码：461 / 471
页数：10
相关论文
共 50 条
  • [41] A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension
    Lacourcière, Y
    Pool, JL
    Svetkey, L
    Gradman, AH
    Larochelle, P
    de Champlain, J
    Smith, WB
    AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (04) : 454 - 461
  • [42] Omega-3 supplementation in young offenders: a randomized, stratified, double-blind, placebo-controlled, parallel-group trial
    Raine, Adrian
    Leung, Chi-Ching
    Singh, Melvinder
    Kaur, Jasmin
    JOURNAL OF EXPERIMENTAL CRIMINOLOGY, 2020, 16 (03) : 389 - 405
  • [43] Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial
    Romo-Nava, Francisco
    Alvarez-Icaza Gonzalez, Deni
    Fresan-Orellana, Ana
    Saracco Alvarez, Ricardo
    Becerra-Palars, Claudia
    Moreno, Julia
    Ontiveros Uribe, Martha P.
    Berlanga, Carlos
    Heinze, Gerhard
    Buijs, Ruud M.
    BIPOLAR DISORDERS, 2014, 16 (04) : 410 - 421
  • [44] Omega-3 supplementation in young offenders: a randomized, stratified, double-blind, placebo-controlled, parallel-group trial
    Adrian Raine
    Chi-Ching Leung
    Melvinder Singh
    Jasmin Kaur
    Journal of Experimental Criminology, 2020, 16 : 389 - 405
  • [45] Intrauterine Instillation of Tranexamic Acid in Hysteroscopic Myomectomy: A Double-Blind, Placebo-Controlled, Parallel-Group Randomized Clinical Trial
    Rasheedy, Radwa
    Makled, Ahmed
    Abou-Gamrah, Amgad
    Giuma, Hajer
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2020, 27 (06) : 1264 - +
  • [46] A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS
    Montalban, Xavier
    Hemmer, Bernhard
    Rammohan, Kottil W.
    Giovannoni, Gavin
    De Seze, Jerome
    Bar-Or, Amit
    Arnold, Douglas L.
    Sauter, Annette
    Masterman, Donna
    Fontoura, Paulo
    Chin, Peter
    Garren, Hideki
    Wolinsky, Jerry S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 17 - 17
  • [47] GABAPENTIN AS ADD-ON THERAPY IN REFRACTORY PARTIAL EPILEPSY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY
    OOMMEN, K
    PENRY, J
    RIELA, A
    ROWAN, AJ
    ROSENBAUM, D
    SCHEAR, M
    SIVAK, M
    WIENER, J
    SAUERMANN, W
    WIBBERG, M
    SMITH, D
    KRAMER, R
    YERBY, M
    LESSER, R
    FISHER, R
    SANDERS, P
    NORTH, R
    HOMAN, R
    ALEXANDER, J
    SHELLENBERGER, MK
    WALLACE, J
    SACKELLARES, J
    AASVED, K
    HIRSCHORN, K
    OLSON, L
    LEPPIK, I
    RASK, C
    ROSENFELD, W
    FROMM, GH
    NAGEL, N
    DREIFUSS, F
    BERTRAM, E
    COOPER, G
    LEE, SI
    OJEMANN, L
    WILENSKY, A
    ABOUKHALIL, B
    COURVILLE, K
    MCLEAN, M
    RAMSAY, RE
    GUTERMAN, A
    MCJILTON, J
    SANCHEZ, R
    SLATER, J
    MATTSON, R
    SCHEYER, R
    TREIMAN, D
    HANDFORTH, A
    NEUROLOGY, 1993, 43 (11) : 2292 - 2298
  • [48] The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study
    Gerhardsen, Gerhard
    Hansen, Anne V.
    Killi, Marianne
    Fornitz, Gitte Gleerup
    Pedersen, Frank
    Roos, Signe Barfod
    ADVANCES IN THERAPY, 2008, 25 (06) : 595 - 607
  • [49] Gabapentin as add-on therapy in refractory partial epilepsy: A double-blind, placebo-controlled, parallel-group study
    McLean, M
    Ramsay, RE
    Leppik, IE
    Rowan, AJ
    Shellenberger, MK
    Wallace, J
    NEUROLOGY, 2001, 57 (11) : S62 - S68
  • [50] The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study
    Gerhard Gerhardsen
    Anne V. Hansen
    Marianne Killi
    Gitte Gleerup Fornitz
    Frank Pedersen
    Signe Barfod Roos
    Advances in Therapy, 2008, 25
12345